Axogen, Inc. — Director's Dealing 2025

Mar 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-03-25

Reporting Person: DALE MICHAEL D (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-25	Restricted Stock Units	$	A	176300	Acquired		Common Stock (176300)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 25, 2029 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 25, 2027 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.